ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
26 announcements
Health X Platform Limited dispatched letters to shareholders with unregistered emails, providing web-links for the FY2025-26 Annual Report and 37th AGM notice.
Health X Platform Limited has filed its Annual Report for the financial year 2025-26. The company reported a consolidated total revenue of Rs. 1,319.27 Crore for the period.
Health X Platform Limited will hold its 37th Annual General Meeting on September 28, 2026, via video conferencing. The meeting notice and annual report will be submitted later.
Health X is aggressively scaling its digital B2B and B2C pharmacy platforms, showing strong top-line momentum while burning cash on technology and geographical expansion.
Health X Platform reports strong Q1 FY27 growth with revenue at ₹440.3 Cr and 7.8% gross margins, leveraging its B2C SastaSundar and B2B Retailer Shakti ecosystems.
Health X Platform Limited has re-appointed Anjana Dikshit as a Non-Executive Independent Director for a 60-month term, effective November 10, 2026.
Health X Platform Ltd reported revenue from operations of ₹446.8 Cr (+49.7% YoY) and net profit of ₹2 Cr (-92.5% YoY) for Q1 FY27.
Health X Platform Ltd won a tax litigation case regarding a service tax demand of ₹0.65 Crore. The authority set aside the demand with no penalties.
Health X Platform Limited will hold a board meeting on August 7, 2026, to consider and approve the company's unaudited standalone and consolidated financial results.
Health X Platform Ltd filed its quarterly shareholding pattern as of June 30, 2026. The filing details the distribution of equity shares among promoters and public shareholders.
Health X Platform (formerly SastaSundar) reported FY26 revenue of ₹1283cr (+18% YoY) and narrowed EBITDA loss to ₹65cr. Strategy focuses on B2B expansion via Retailer Shakti and new JITO private labels.
Health X Platform approved a scheme of amalgamation to consolidate its healthcare and financial subsidiaries. The merger aims to streamline operations and enhance shareholder value through unified governance.
Health X Platform approved the demerger of its ₹15.19 Crore financial services division. The move aims to unlock shareholder value and enable independent business growth.
Health X Platform Ltd (formerly Sastasundar) announced a corporate restructuring to separate its Healthcare Services and Financial Services businesses into distinct listed entities to enhance focus and value.
Health X Platform approved a composite scheme to demerge its financial services business into a separate entity. The move aims to unlock value and create focused business structures for shareholders.
Health X Platform's board approved a composite scheme of arrangement involving demergers and amalgamations. The restructuring aims to unlock value by segregating financial and healthcare services.
Promoter Ravi Kant Sharma sold 2,50,000 shares of Health X Platform Limited via open market sale. Total promoter group holding reduced from 74.85% to 74.07%.
Promoter Ravi Kant Sharma sold 2,50,000 equity shares of Health X Platform Limited via open market. The transaction was valued at ₹7.50 Crore.
Health X Platform Limited updated its official website to healthxplatform.com following its corporate name change. This administrative update ensures digital presence alignment with the new identity.
Health X Platform (formerly Sastasundar Ventures) reports Q4 FY26 revenue of ₹378cr with focus on AI-powered digital health across B2B (Retailer Shakti) and B2C platforms.
Health X Platform Ltd reported revenue from operations of ₹373.8 Cr (+30.8% YoY) and a net loss of ₹13 Cr for Q4 FY26.
Health X Platform approved its audited FY26 financial results. The consolidated annual revenue reached ₹1,319.27 Crore, demonstrating significant scale despite reportable losses during the period.
Health X Platform Limited filed its Annual Secretarial Compliance Report for the financial year 2026. The report confirms overall compliance with SEBI statutory requirements and regulations.
Health X Platform scheduled a board meeting on May 30, 2026. Directors will consider audited standalone and consolidated financial results for the 2026 fiscal year.
Sastasundar Ventures Limited received approval from BSE and NSE to change its name to Health X Platform Limited. The new trading symbol will be HEALTHX, effective April 30, 2026. This administrative update follows the receipt of a new Certificate of Incorporation from the Registrar of Companies.
Health X Platform Limited (formerly Sastasundar Ventures) submitted its quarterly compliance certificate under Regulation 74(5) of SEBI Regulations for the period ended March 31, 2026. The registrar, MUFG Intime India, confirmed that security certificates received for dematerialisation were processed and cancelled within prescribed timelines.